The signal transducer and activator of transcription, STAT5b, has been implicated in signal transduction pathways for a number of cytokines and growth factors, including growth hormone (GH). Pulsatile but not continuous GH exposure activates liver STAT5b by tyrosine phosphorylation, leading to dimerization, nuclear translocation, and transcriptional activation of the STAT, which is proposed to play a key role in regulating the sexual dimorphism of liver gene expression induced by pulsatile plasma GH. We have evaluated the importance of STAT5b for the physiological effects of GH pulses using a mouse gene knockout model. STAT5b gene disruption led to a major loss of multiple, sexually differentiated responses associated with the sexually dimorphic pattern of pituitar y GH secretion. Malecharacteristic body growth rates and male-specific liver gene expression were decreased to wild-type female levels in STAT5b ؊͞؊ males, while female-predominant liver gene products were increased to a level intermediate between wild-type male and female levels. Although these responses are similar to those observed in GH-deficient Little mice, STAT5b ؊͞؊ mice are not GH-deficient, suggesting that they may be GH pulseresistant. Indeed, the dwarfism, elevated plasma GH, low plasma insulin-like growth factor I, and development of obesity seen in STAT5b ؊͞؊ mice are all characteristics of Laron-type dwarfism, a human GH-resistance disease generally associated with a defective GH receptor. The requirement of STAT5b to maintain sexual dimorphism of body growth rates and liver gene expression suggests that STAT5b may be the major, if not the sole, STAT protein that mediates the sexually dimorphic effects of GH pulses in liver and perhaps other target tissues. STAT5b thus has unique physiological functions for which, surprisingly, the highly homologous STAT5a is unable to substitute.
Growth hormone (GH) has diverse physiological actions and regulates the tissue-specific expression of numerous genes involved in growth, metabolism, and differentiation (1, 2) . Several of the effects of GH on somatic growth and gene expression are sex-dependent and are regulated by pituitary GH secretory patterns, which are sexually differentiated. The resultant sex differences in plasma GH profiles are particularly striking in rodents (for example, intermittent GH pulses in male rats vs. continuous plasma GH in female rats) and are the major determinant of sex differences in body growth rates and the sexually dimorphic expression in liver of numerous genes, including the major urinary proteins (MUP) (3), prolactin receptors (3, 4) , and several cytochrome P450 (CYP) enzymes (5) (6) (7) . Altering the temporal pattern of plasma GH by GH infusion or by hypophysectomy with GH replacement causes changes in body growth rate and in the patterns of liver gene expression that directly reflect the changes in plasma GH profiles (3, 5, 8) . In mice, GH secretion is pulsatile in both males and females; however, the interval between pulses is longer in males (9) , and this period of low or no plasma GH is thought to be an important determinant of the male-specific pattern of liver gene expression (8) .
Recently, STAT5, a latent cytoplasmic transcription factor, has been shown to be activated in rat liver by the male pulsatile pattern of GH stimulation but not by the more continuous GH pattern that occurs in females (10) . This activation, which involves GH pulse-induced STAT5 tyrosine phosphorylation followed by serine or threonine phosphorylation (11, 12) , induces nuclear translocation of STAT5 and has been proposed to be a key event in mediating the effects of GH pulses on male-specific liver gene expression (10) . Most of this STAT5 appears to be STAT5b (11, 13) , which belongs to a gene family, the signal transducers and activators of transcription, whose members are resident in the cytosol but become activated to nuclear DNA-binding proteins following the binding of cytokines and growth factors to their cognate cellsurface receptors. STAT5 was originally identified as a prolactin-inducible transcription factor in lactating mammary gland (14) (15) (16) . Subsequently, two highly homologous STAT5 genes (17, 18) , STAT5a and STAT5b, were found to be expressed in a wide range of tissues (17) (18) (19) (20) . These STATs can be activated by many growth factors and cytokines, including prolactin (21), GH (10, 22, 23) , interleukins (20, 24) , epidermal growth factor (25, 26) , and erythropoietin (27) . The high (Ϸ96%) sequence similarity between STAT5a and STAT5b suggests that there may be redundancy in their signaling pathways. However, subtle differences in the tissue distribution of STAT5a and STAT5b mRNAs suggest that they may have distinct functions (19) . Targeted disruption of STAT genes, either individually or in combinations, is now allowing elucidation of the specific functions of each STAT (28) (29) (30) (31) (32) (33) (34) . We have targeted the STAT5b gene to define its function and, in particular, to assess its proposed role in the GH pulseregulated sexual dimorphism of liver gene expression.
EXPERIMENTAL PROCEDURES
Target Vector and Gene Disruption. Clones containing the murine STAT5b gene were isolated from a 129 mouse genomic DNA library (Stratagene) and used to construct a positive͞ negative selection vector for targeting the gene. The vector was constructed by inserting a neomycin resistance (neo r ) cassette at the BamHI site interrupting the codon for amino acid 181. It contained 0.9 kb of 5Ј DNA, 12 kb of 3Ј DNA, and the herpes simplex virus thymidine kinase gene to allow negative selection (Fig. 1A) . Embryonic stem cells were electroporated and selected, and targeted clones were injected into blastocysts to obtain chimaeric mice that transmitted the disrupted locus through the germ line. A 1-kb ApaI͞EcoRV fragment was used for Southern blot analysis. BglII restriction fragments were 8 kb for the wild-type allele and 4.7 kb for the targeted allele (Fig.  1B) . Electroporation of embryonic stem cells, cell selection, and cell and mouse screening have been described (35) . Experiments described in this report were carried out using littermates obtained from 129 ϫ BALB͞c outcrossed mice. Western Blot and Gel Shift Analyses. Liver cytosolic proteins prepared from 8-to 9-week-old wild-type and STAT5b Ϫ͞Ϫ mice by ultracentrifugation were analyzed on Western blots probed sequentially with anti-STAT antibodies (11) . Western blots of mouse liver microsomes (25 g per lane) were probed with anti-rat CYP3A monoclonal antibody 2-3-2 (36) or anti-mouse CYP2D [anti-C-P450 16␣ , provided by M. Negishi, National Institute on Environmental Health Sciences (NIEHS), Research Triangle Park, NC (5)] as described (37) . Gel shift assays used mouse liver nuclear extracts (38) and a rat ␤-casein gene STAT5 binding site probe (10) in the absence or presence of a supershifting anti-STAT5a antibody (sc-1081x, Santa Cruz Biotechnology).
Northern Blot Analyses. Total liver RNA (5 g) was run on a 0.8% agarose͞formaldehyde gel, transferred to nylon, and sequentially hybridized and stripped with cDNA probes for CYP 15␣ ͞2A4 (M. Negishi, NIEHS), the short form of the prolactin receptor (P. Kelly, Institut National de la Santé et de la Recherche Médicale, Paris), and an oligonucleotide for 28S rRNA. Relative RNA band intensities were measured using the IMAGE 1.57 program (NIH). STAT5b mRNA (5.6 kb) and STAT5a mRNA (4.2 kb) (19) in wild-type and STAT5b Ϫ͞Ϫ mouse tissues were analyzed by Northern blotting (10 g RNA) using a 1.1-kb 5Ј-end STAT5b cDNA isolated from a mouse 129 brain cDNA library (Stratagene).
Other Methods. Mice were weighed regularly from birth to 42 days of age (n ϭ 194 individual mice), and the body weight means were adjusted for small variations between litters. GENSTAT 5 software was used for statistical analysis. Plasma IGF-I levels (39) and plasma GH levels at sacrifice (rat GH RIA kit, Amersham) were measured by standard methods. Serum progesterone was measured by RIA (Diagnostic Products, Los Angeles) using tail vein blood samples collected every 3 days of pregnancy. To analyze MUP protein levels, morning and afternoon urines were combined and centrifuged (1,000 g ϫ 3 min). The supernatant (0.5 l) was analyzed on a 12% SDS-polyacrylamide gel stained with Coomassie blue. Testosterone hydroxylase activity was measured in mouse liver microsomes prepared by differential centrifugation (37) .
RESULTS

STAT5b Gene Disruption. Matings of STAT5b
ϩ͞Ϫ mice (129 ϫ BALB͞c outcross) produced STAT5b Ϫ͞Ϫ offspring that were close to the expected Mendelian frequency. Northern blot analyses failed to detect STAT5b mRNA in liver, spleen, mammary gland, thymus, kidney, or skeletal muscle of STAT5b Ϫ͞Ϫ mice, and Western blotting of protein extracts of these same tissues detected STAT5b protein in wild-type but not STAT5b Ϫ͞Ϫ mice. By contrast, STAT5a mRNA (data not shown) and protein were present in both wild-type and STAT5b Ϫ͞Ϫ mice at levels similar to those in wild-type mice ( Fig. 1C ; data not shown). This STAT5a was functionally active in a DNA-binding gel-shift assay using a ␤-casein gene STAT5 binding-site probe (Fig. 1D ). Supershift analysis using antiSTAT5a antibodies revealed a complete supershifting of the STAT5-DNA complex in STAT5b Ϫ͞Ϫ liver nuclear extracts (lane 4) but an incomplete supershift in STAT5b ϩ͞ϩ samples. Presumably, the residual, unshifted band represents STAT5b homodimers bound to the DNA probe. Liver STAT3 protein levels were unchanged or slightly increased by the STAT5b gene knockout, whereas liver STAT1 protein levels were increased more substantially (Fig. 1C) .
Decreased Growth of STAT5b ؊͞؊ Males. Examination of two independent lines of STAT5b Ϫ͞Ϫ mice revealed striking decreases in body weight gain for STAT5b Ϫ͞Ϫ males that were not seen in STAT5b Ϫ͞Ϫ females (Fig. 2) . STAT5b
Ϫ͞Ϫ males grew at the lower rate, which is characteristic of wild-type female mice, thereby abolishing the striking sexual dimorphism in body growth rate normally evident from 3 weeks of age. This sex difference in body growth is determined by the sex-specific pattern of pituitary GH secretion (8, 40, 41) , which first emerges at this stage in development (1) . At 4 to 5 weeks of age, STAT5b Ϫ͞Ϫ males were 27% lighter than wild-type males, and this difference persisted beyond puberty (Fig. 2) . X-rays and alizarin red staining showed that the skeletons of STAT5b Ϫ͞Ϫ males were smaller than wild-type males but otherwise appeared normal (data not shown). There were no obvious histological defects or weight differences in abdominal or thoracic organs, although the livers in some STAT5b Ϫ͞Ϫ mice were pale and enlarged. These phenotypic effects of STAT5b disruption, as well as the effects on reproduction (see below), were observed for two independent lines of STAT5b Ϫ͞Ϫ mice.
Analysis of circulating hormone levels revealed normal to elevated plasma GH levels in STAT5b Ϫ͞Ϫ males at the time of sacrifice (46 Ϯ 4 ng͞ml for wild-type vs. 89 Ϯ 33 ng͞ml for STAT5b Ϫ͞Ϫ males, reflecting elevated GH in three of the six knockout males). No significant plasma GH differences were seen in females [51 Ϯ 15 (wild type) vs. 54 Ϯ 13 ng͞ml (STAT5b Ϫ͞Ϫ females)]. Plasma IGF-I concentrations were significantly lower in STAT5b Ϫ͞Ϫ mice (197 Ϯ 13 ng͞ml) than in STAT5b ϩ͞ϩ mice (282 Ϯ 15 ng͞ml) (P Ͻ 0.001), with no sex differences apparent. GH rapidly stimulates the transcriptional activation of IGF-I in liver, but the role of STAT proteins in this response is unknown.
Loss of GH Pulse-Regulated, Sexually Dimorphic Liver Gene Expression. To determine whether STAT5b is required for expression of sex-dependent differences in liver gene expression, we compared the amounts of MUP in the urine of STAT5b Ϫ͞Ϫ and wild-type mice. MUP is a family of ␣2-microglobulin-related liver secretory proteins that comprise a major protein component of mouse urine. MUP protein is excreted in male mouse urine at levels that are Ϸ3-fold higher than in female urine (3). Induction of MUP by pulsatile plasma GH, a characteristic of males, has been demonstrated using GH-deficient Little mice (3). Little mice have very low levels of MUP, and GH replacement by intermittent injection (to mimic the male pulsatile GH pattern) specifically increases MUP to normal male levels (3). We found MUP levels in urine from STAT5b Ϫ͞Ϫ males similar to the amounts in female urine and considerably less than in wild-type males (Fig. 3) . A simple interpretation of our data, consistent with published findings on the pulsatile GH activation of liver STAT5 (10) , is that STAT5b is required for the male-specific pulsatile GH induction of MUP and, consequently, STAT5b Ϫ͞Ϫ males are unable to respond to the male pulsatile GH secretory pattern. We also noted lower levels of MUP when STAT5b Ϫ͞Ϫ females were compared with wild-type females (Fig. 3) , indicating that there are also some STAT5b-dependent effects on MUP gene expression in females. This latter finding may relate to the multihormonal control reported for MUP protein expression (42) , and is analogous to the lower MUP levels that female Little mice have compared with wild-type females (3).
Liver expression of several CYP enzymes and other liver gene products is sex-specific and regulated by the plasma GH pattern (5) (6) (7) (8) . P450 15␣ hydroxylase (CYP2A4) and prolactin receptors are both expressed predominantly in female mice, and their expression is known to be primarily regulated by GH (3, 5) with some influences from other hormones such as thyroxine. Northern blots therefore were used to compare mRNA levels of these CYP enzymes, and of prolactin recep-FIG. 2. Growth curves of wild-type (ϩ͞ϩ) and STAT5b Ϫ͞Ϫ (Ϫ͞Ϫ) mice, and 42-day-old wild-type and STAT5b Ϫ͞Ϫ males from the same litter (Insert). Body weights of wild-type males were significantly different from STAT5b Ϫ͞Ϫ males (M) and females (F) (P Յ 0.001). No significant differences were seen between STAT5b Ϫ͞Ϫ males, wildtype females, and STAT5b Ϫ͞Ϫ females. Standard errors of differences (SED) are indicated on the x axis. FIG. 3 . SDS gel analysis of MUP in urine of wild-type (ϩ͞ϩ), STAT5b ϩ͞Ϫ (ϩ͞Ϫ), and STAT5b Ϫ͞Ϫ (Ϫ͞Ϫ) mice stained with Coomassie blue. Densitometric analysis revealed statistically significant differences between the wild type and knockout for both male genotypes (P Ͻ 0.005 for ϩ͞ϩ vs. ϩ͞Ϫ and ϩ͞ϩ vs. Ϫ͞Ϫ) and female genotypes (P Ͻ 0.02 for ϩ͞ϩ vs. Ϫ͞Ϫ). Other comparisons within each sex were not significant (P Ͼ 0.05; two-tailed Student's t test).
tors, in the livers of STAT5b
Ϫ͞Ϫ and wild-type mice. Although there was variation between animals, the expression of P450 15␣ mRNA was elevated in STAT5b Ϫ͞Ϫ males to a level somewhat lower than that in wild-type females (Fig. 4A) . The same trend of increased expression of prolactin receptors was seen in STAT5b Ϫ͞Ϫ males (Fig. 4B) . The individual animal variation seen in these samples may be due to the random genetic contribution from the 129 ϫ BALB͞c outcrossed background, because these two strains are known to differ in their patterns of expression of these proteins (43) . Similarly, STAT5b gene disruption in males increased expression of the femaledominant liver CYP3A proteins and their associated microsomal testosterone 6␤-hydroxylase activity to near-female levels (Fig. 5) . By contrast, no effect was seen on liver microsomal testosterone 2␣-hydroxylase, a sex-independent mouse liver P450 activity. STAT5b Ϫ͞Ϫ males also exhibited a selective loss of the steroid 16␣-hydroxylase protein CYP2D9 (C-P450 16␣ , Fig. 5B Lower, band b) , which is expressed in a male-specific fashion in mouse liver under the positive influence of plasma GH pulses (5) .
Other Phenotypes of STAT5b ؊͞؊ Mice. In addition to the phenotypic effects of STAT5b gene disruption on body growth and liver gene expression, we observed effects on lactation, reproduction, fat deposition, and hair growth. Preliminary analyses indicated that mammary gland development is impaired in STAT5b Ϫ͞Ϫ females, and although milk protein genes are expressed (Northern and Western blot analyses), there is insufficient milk to feed pups (data not shown). STAT5b Ϫ͞Ϫ females consistently aborted between day 8 and 17 of pregnancy, with no obvious maternal, placental, or fetal defects. Heterozygous females were also affected, with higher numbers of pups dying perinatally than with wild-type females, and these deaths were not associated with the genotype of the pups. Subcutaneous delivery of progesterone (about 4 mg; s.c. implantation on day 5 to 7 of pregnancy of a 5 ϫ 1.5 ϫ 1.5-mm segment of a controlled intravaginal drug release device; CIDR, InterAg, Hamilton, New Zealand) maintained pregnancy in STAT5b Ϫ͞Ϫ females. In the absence of progesterone implants, serum progesterone declined precipitously by day 12 of pregnancy in STAT5b Ϫ͞Ϫ mice, while in STAT5b ϩ͞ϩ mice progesterone remained high until parturition (data not shown).
The effects of STAT5b disruption on body fat deposition were marked, with significantly less adipose tissue in both STAT5b Ϫ͞Ϫ females and males compared with wild-type mice. Weights of sublumbar adipose tissue showed that the effect was greater in females (reduced to 36% of wild-type) than males (69% of wild-type). In addition, although there were low amounts of fat in young adult STAT5b Ϫ͞Ϫ mice, obesity became apparent in some of the mice beginning at about 9 weeks of age, and these individuals had large testicular fat pads and greater amounts of abdominal fat. Numerous cells had no lipid, suggesting that adipocyte differentiation might indeed be impaired (data not shown). GH induces the differentiation of preadipocytes to adipocytes (44) and can activate STAT5 in 3T3-F442A mouse preadipocytes in culture (22) , indicating a potential role for STAT5 in adipocyte differentiation.
Examination of the hair of STAT5b Ϫ͞Ϫ mice revealed no structural abnormalities, but the pelage of some animals was sparse. To observe new hair growth, the hair was dyed when the mice were 25 days old. This revealed a delay of at least 2 weeks in the commencement of second-generation hair growth in STAT5b Ϫ͞Ϫ mice. Further study is required to ascertain whether these latter effects of STAT5b gene disruption reflect an insensitivity of target tissues to GH, or whether they result from loss of responsiveness to other cytokines and growth factors that also signal via STAT5b.
DISCUSSION
We have shown that STAT5b gene disruption leads to a major loss of multiple, sexually differentiated responses associated Shown at Top are three CYP3A-immunoreactive proteins detected using anti-rat CYP3A antibody; bands marked b and c are both female-dominant and are increased in male STAT5b Ϫ͞Ϫ mice. Shown at Bottom are three CYP2D-immunoreactive proteins detected using anti-mouse C-P45016␣ antibody; band b exhibits the male predominance reported for the C-P45016␣ (5) and is decreased to female levels in male STAT5b Ϫ͞Ϫ mice.
with the sexually dimorphic pattern of pituitary GH secretion. Male-characteristic body growth rates and male-specific liver gene expression are decreased to wild-type female levels in STAT5b Ϫ͞Ϫ males (MUP, CYP2D9), while female-predominant liver gene products are increased in males to a level intermediate between wild-type male and female levels (CYP 15␣ ͞2A4, CYP 6␤ ͞3A, and prolactin receptors). These responses are very similar to those observed in GH-deficient Little mice and support our hypothesis (10) that STAT5b is the major, if not the sole, STAT protein that mediates the sexually dimorphic effects of GH on the liver and perhaps other target tissues. The closely related STAT5a [96% sequence identity; (17, 18) ] is a minor STAT5 form in rat liver (11, 13) . However, the present studies indicate that although STAT5a can be detected in an active form in the liver (Fig. 1D) , it alone is insufficient to maintain normal sexually dimorphic GH responses. Liver STAT1 and STAT3 also respond to GH (11, 45, 46) ; however, neither of these STATs exhibits the striking discrimination between intermittent and continuous GH stimulation seen with STAT5 (11), and the present study suggests that neither is likely to play an important role in the sexually dimorphic effects of GH. Interestingly, STAT1 protein expression was up-regulated in both male and female STAT5b Ϫ͞Ϫ mice in what may be an attempt at a compensatory response to the loss of STAT5b expression; however, the significance of this STAT1 increase and its possible contribution to the observed STAT5b Ϫ͞Ϫ phenotype are unclear.
The phenotype of STAT5b gene disruption in males contrasts with the lack of a major effect on liver gene expression or body growth rates in STAT5b Ϫ͞Ϫ females. A modest decrease in growth rate is seen in STAT5b Ϫ͞Ϫ females, a finding that could relate to the lower circulating IGF-I levels seen in these animals. This finding is in accord with reports on GH-deficient Little mice, where loss of circulating GH has a much less pronounced effect in females than males (5) , and further supports the proposal that, in the mouse model, male GH pulses can both positively regulate male-specific liver gene expression and can negatively regulate female-predominant gene expression (5) . In contrast to these STAT5b-dependent effects of GH pulses, studies in the rat model demonstrate that continuous GH can positively regulate female-specific liver gene products, such as CYP2C12, by activation of a novel signaling pathway that appears to be independent of STAT factors (47) .
The mechanism underlying the loss of sexually dimorphic body growth rates and liver gene expression in STAT5b Ϫ͞Ϫ mice is uncertain but could reflect either of two possibilities. The simplest explanation is that STAT5b is necessary for (and perhaps directly mediates) the physiological effects of male plasma GH pulses on body growth rates and liver gene expression. This possibility is strongly supported by the direct response of liver STAT5b, but not other STAT forms, to the male pattern of plasma GH pulsation (10, 11) , which previously has been established as being both necessary and sufficient to achieve male body growth rates (8, 40, 41) and male liver gene expression (5) (6) (7) (8) . One prediction of this hypothesis is that at least some of the sexually dimorphic liver gene products whose expression is altered in STAT5b Ϫ͞Ϫ males (Figs. 3-5 ) will contain functional STAT5b-binding DNA response elements in their genes. Indeed, at least two malespecific, GH pulse-regulated liver CYP genes in other rodent species contain functional STAT5 binding sites in their 5Ј-flanking DNA (S.-H.P. and D.J.W., unpublished data; ref. 48 ). An alternative possibility is that the apparent feminization of body growth rates and liver enzyme patterns in STAT5b Ϫ͞Ϫ mice is a secondary response to a general loss of circulating GH or perhaps a loss of the male pattern of pulsatile pituitary GH secretion. Although the phenotype of the STAT5b Ϫ͞Ϫ mouse does have important similarities to that of the GH-deficient Little mouse, as noted above, STAT5b Ϫ͞Ϫ mice are, in fact, not GH-deficient, as demonstrated by the presence of circulating GH at sacrifice in both males and females at levels at least comparable to those of corresponding wild-type mice. It is possible, however, that the temporal pattern of pituitary GH release is perturbed in STAT5b Ϫ͞Ϫ mice in a manner such that female growth rates and a liver enzyme phenotype result (compare apparent elevation in plasma GH levels in three of six individual STAT5b Ϫ͞Ϫ males). Further experimentation, including a direct analysis of the pulsatility of circulating GH profiles in STAT5b Ϫ͞Ϫ mice, is required to address this point. It should be noted, however, that in Laron-type dwarfism, a human GH-resistance syndrome most commonly associated with GH receptor defects, changes in plasma GH patterns, including elevated peak GH levels, are observed (49) . Thus, if the STAT5b Ϫ͞Ϫ mouse is indeed a GH pulse-resistant animal model, then any alteration of circulating GH patterns in these animals would still leave unanswered the question of whether such a change is a secondary response, as is seen with other examples of GH pulse resistance, or whether the altered GH profile is a primary consequence of the STAT5b gene disruption, which, in turn, causes the growth rate and liver enzyme phenotypes described in this report. The apparent GH resistance of our STAT5b Ϫ͞Ϫ mice, as well as the dwarfism, elevated plasma GH, lower IGF-I, and the development of obesity that we have seen are all characteristics of Laron-type dwarfism (49) . This raises the interesting possibility that cases of nonclassical Laron-type dwarfism, which are associated with post-GH receptor defects (50, 51) , may include examples of STAT5b defects.
Although our findings establish that STAT5b is needed for the plasma GH-regulated sexual dimorphism of liver gene expression, additional factors are also likely to be required for this response. This is indicated by the rapid (within 10 min) activation of liver STAT5 by a physiological GH pulse given in vivo (10, 11) , which contrasts to the much slower response of male-specific liver CYP gene transcription (52) and mRNA expression (5) to GH pulsation, and by the relatively modest stimulatory effect demonstrated for a STAT5 response element when analyzed in cultured cell transfection studies of a GH-regulated male-specific hamster liver CYP gene (48) . Further study is required to identify these other factors and to establish the underlying mechanisms through which STAT5b would appear to regulate the male pattern of long bone growth that is characteristic of many species, including humans.
Finally, comment should be made on the evolution of the STAT gene family. Recent work suggests that STATs 1-4 and STAT6 arose by a series of chromosome duplications from an ancestral STAT5 gene (53, 54) . Presumably, each of these genes diverged and subsequently evolved unique and essential roles in one or more cytokine signaling pathways. Indeed, this conclusion is supported by gene-disruption experiments involving STATs 1, 4, and 6 (28) (29) (30) (31) (32) (33) . One would likewise predict that the STAT5a and STAT5b genes would have properties that are similar to each other, but quite distinct from STATs 1-4 and STAT6, given their high homology (53) . Although this may be the case for some STAT5-dependent phenotypes, such as prolactin-dependent responses of mammary gland (cf. this study with ref. 34) , our data clearly show that in the liver, endogenous STAT5a expression cannot substitute for a global STAT5b gene deficiency. Whether this results from intrinsic differences in the activities of STAT5a and STAT5b or from differences in their patterns of expression within the liver or other critical tissues cannot presently be determined. Further studies, including analysis of liver gene expression patterns in STAT5a gene knockout mice, either alone (34) or in combination with STAT5b gene disruption, may help answer these questions.
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